| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/10/2005 | EP1561818A1 Nucleic acids and polypeptides of drosophila melanogaster SNF sodium-neurotransmitter symporter family cell surface receptors and methods of use |
| 08/10/2005 | EP1561817A2 Modified CEA and uses thereof |
| 08/10/2005 | EP1561816A1 Methods for determining genetic resistance of pigs to diseases caused by rna viruses |
| 08/10/2005 | EP1561815A2 Tissue-specific and target rna-specific ribozymes |
| 08/10/2005 | EP1561814A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 08/10/2005 | EP1561813A1 Isomaltose synthase-knockout microorganism belonging to eumycota |
| 08/10/2005 | EP1561812A1 Modified sarcosine oxidase, process for producing the same and reagent composition using the same |
| 08/10/2005 | EP1561810A2 Mutant microorganism and method for producing peptide using the same |
| 08/10/2005 | EP1561809A2 Eucaryotic cell expressing phycocyanin |
| 08/10/2005 | EP1561807A1 Method of degrading hardly degradable protein |
| 08/10/2005 | EP1561758A1 Method for isolating and purifying viruses from plant sources |
| 08/10/2005 | EP1561757A1 Modified factor VIII |
| 08/10/2005 | EP1560939A2 Immobilization of biological molecules onto surfaces coated with monolayers |
| 08/10/2005 | EP1560935A2 Self-containing lactobacillus strain |
| 08/10/2005 | EP1560933A2 Methods and compositions for treating neurological disorders |
| 08/10/2005 | EP1560931A2 Functional and hyperfunctional sirna |
| 08/10/2005 | EP1560928A2 Nucleic acid ligands and uses therefor |
| 08/10/2005 | EP1560926A2 Novel buffer formulations for isolating, purifying and recovering long-chain and short-chain nucleic acids |
| 08/10/2005 | EP1560925A2 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 08/10/2005 | EP1560920A2 Food flours with specific technological characteristics and low allergenicity |
| 08/10/2005 | EP1560919A2 Improved hybrid gene libraries and uses thereof |
| 08/10/2005 | EP1560918A2 Compositions and methods for the modulation of viral maturation |
| 08/10/2005 | EP1560853A2 Intracellular antibodies |
| 08/10/2005 | EP1560849A1 Growth hormone variations in humans and its uses |
| 08/10/2005 | EP1560845A1 Vaccine against hcv |
| 08/10/2005 | EP1560844A1 Hepatitis c vaccine |
| 08/10/2005 | EP1560840A2 Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| 08/10/2005 | EP1560839A2 Chimeric oligomeric compounds and their use in gene modulation |
| 08/10/2005 | EP1560597A2 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 08/10/2005 | EP1560593A1 Novel composition and methods for the treatment of immune related diseases |
| 08/10/2005 | EP1560490A2 Coronary artery disease treatment |
| 08/10/2005 | EP1560484A2 Refined plant transformation |
| 08/10/2005 | EP1499895A4 Functionalized nanoparticles and methods of use |
| 08/10/2005 | EP1461457A4 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness |
| 08/10/2005 | EP1434880A4 Method and apparatus for amplification of nucleic acid sequences by using thermal convection |
| 08/10/2005 | EP1427851A4 Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| 08/10/2005 | EP1421096A4 CONSTITUTIVE PHOTOMORPHOGENESIS 1 (COP1) NUCLEIC ACID SEQUENCE FROM i ZEA MAYS /i AND ITS USE THEREOF |
| 08/10/2005 | EP1409711A4 Compositions and methods for increasing amino acid absorption in mammals |
| 08/10/2005 | EP1404809A4 Improved skin substitutes and uses thereof |
| 08/10/2005 | EP1356063B8 Expression of multiple proteins in transgenic plants |
| 08/10/2005 | EP1337643A4 Manipulation of plant life cycles and/or growth phases |
| 08/10/2005 | EP1336088B1 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium |
| 08/10/2005 | EP1292697A4 Method for preparing a physiologically active il-18 polypeptide |
| 08/10/2005 | EP1169441B8 Pharmaceutical compositions for the treatment of heart failure |
| 08/10/2005 | EP1151117A4 Intein-mediated protein ligation of expressed proteins |
| 08/10/2005 | EP1133559B1 Human orphan g protein-coupled receptor rup3 |
| 08/10/2005 | EP1131420B1 Nucleic acid isolation |
| 08/10/2005 | EP1123398B1 Molecular pathogenicide mediated plant disease resistance |
| 08/10/2005 | EP1096941B1 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 08/10/2005 | EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 08/10/2005 | EP1083788B1 Transgenic fish carrying a bacteriophage-derived transgene construct for mutation detection |
| 08/10/2005 | EP1082427B1 Insulin-like growth factor binding protein-3 variants |
| 08/10/2005 | EP1068306B1 Pentaerythritol lipid derivatives |
| 08/10/2005 | EP1051487B1 Placental protein 13 |
| 08/10/2005 | EP1003898B1 Integrin-targeting vectors having transfection activity |
| 08/10/2005 | EP0973913B1 Soybean plant producing seeds with reduced levels of raffinose saccharides and phytic acid |
| 08/10/2005 | EP0968288B1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
| 08/10/2005 | EP0966685B1 Protein fragment complementation assays to detect biomolecular interactions |
| 08/10/2005 | EP0939652B1 Use of antibodies to cd45ro leukocyte antigen for immunomodulation |
| 08/10/2005 | EP0935674B1 Method for positioning of clones by molecular combing |
| 08/10/2005 | EP0914344B8 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 08/10/2005 | EP0914150B1 Recombinant neospora antigens and their uses |
| 08/10/2005 | EP0906443B1 Generating replicating molecules in vivo |
| 08/10/2005 | EP0901527B1 Regulating metabolism by modifying the level of trehalose-6-phosphate |
| 08/10/2005 | EP0877811B1 Mutated prenyl diphosphate synthases |
| 08/10/2005 | EP0839201B1 Cathepsin-l, the pre-proform thereof and the corresponding propeptide from ciliates |
| 08/10/2005 | EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 08/10/2005 | EP0772684B1 Amylolytic enzymes derived from the b. licheniformis alpha-amylase, having improved characteristics |
| 08/10/2005 | EP0542929B1 Glycogen biosynthetic enzymes in plants |
| 08/10/2005 | CN1653338A Automated system for isolating, amplifying and detecting a target nucleic acid sequence |
| 08/10/2005 | CN1653337A Subunit vaccines with A2 supermotifs |
| 08/10/2005 | CN1653335A Universal libraries for immunoglobulins |
| 08/10/2005 | CN1653334A Biomolecular substrate, method of testing or diagnosis with use thereof and apparatus therefor |
| 08/10/2005 | CN1653194A Application of cantilevers in nucleic acid sequencing |
| 08/10/2005 | CN1653193A 'doping' in walk-through mutagenesis |
| 08/10/2005 | CN1653192A Methods for evaluating a disease condition by nucleic acid detection and fractionation |
| 08/10/2005 | CN1653186A Methods for producing sulphurous fine chemicals by fermentation using metH-coding coryneform bacteria |
| 08/10/2005 | CN1653185A Method for transferring molecules in vital cells by means of laser beams and arrangement for carrying out said method |
| 08/10/2005 | CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 08/10/2005 | CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 08/10/2005 | CN1653182A Recombinant fowlpox virus |
| 08/10/2005 | CN1653181A Expression of genes in modified vaccinia virus ankara by using the cowpox ATI promoter |
| 08/10/2005 | CN1653180A Nucleotide sequence of threonine operon irrepressible by isoleucine and method for producing L-threonine using transformed host cell containing the same |
| 08/10/2005 | CN1653179A Cartilage regeneration using chondrocyte and TGF-beta |
| 08/10/2005 | CN1653178A SCYTALONE dehydrogenase gene showing tolerance to agricultural pesticide |
| 08/10/2005 | CN1653177A Muteins of placental growth factor type 1, preparation method and application thereof |
| 08/10/2005 | CN1653176A Compositions and methods for generating an immune response |
| 08/10/2005 | CN1653175A RNA detection enzyme |
| 08/10/2005 | CN1653174A Methods for increasing oil content in plants |
| 08/10/2005 | CN1653171A Conductive microplate |
| 08/10/2005 | CN1653086A Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis C virus |
| 08/10/2005 | CN1653085A Fusion protein of HIV regulatory/accessory proteins |
| 08/10/2005 | CN1653084A Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 08/10/2005 | CN1653080A Lymphatic and blood endothelial cell genes |
| 08/10/2005 | CN1653079A Intercalator containing pseudonucleotide(s) |
| 08/10/2005 | CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA) |
| 08/10/2005 | CN1652819A Attenuation of metapneumovirus |
| 08/10/2005 | CN1652815A Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
| 08/10/2005 | CN1652681A Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content |
| 08/10/2005 | CN1651917A Microarray hybridization assembly device and preparing process thereof |